论文部分内容阅读
经肝动脉灌注化疗栓塞治疗转移性肝癌的临床价值正逐渐引起重视 ,但其疗效难以肯定 ,究其原因主要可能与门静脉参与转移性肝癌的供血有关 ,因此不少作者主张肝动脉化疗栓塞和门脉化疗双重途径治疗转移性肝癌[1,2 ] 。为此我们自1996～ 2 0 0 1年对 3 8例转移性肝癌采用肝动脉化
The clinical value of transcatheter arterial chemoembolization in the treatment of metastatic liver cancer is receiving more and more attention. However, the curative effect is difficult to confirm. The main reason may be related to the involvement of portal vein in the metastasis of liver cancer. Therefore, many authors advocate the treatment of hepatic arterial chemoembolization The dual approach of pulse chemotherapy for the treatment of metastatic liver cancer [1,2]. To this end, we conducted hepatic arterialization on 38 cases of metastatic liver cancer from 1996 to 2001